Wadegarret...BBC...I wouldn't compare BBC to HSOA. I think Herb Greenberg is more reputable than Stocklemon. Also, one is a Chinese smallcap company and the other is in the U.S. BBC may recover, but it's not going to be by instituional buyers but more by speculators who are guessing. At least with HSOA you can drive to the company and talk with them in person and check out the facilities. The average person doesn't know what's going on in China. Both are risky, but with HSOA the risk can be reduced through onsite inspection and conversation and personal DD. As such, HSOA is more likely to be bought by mutual funds if it is legit. What I'm saying is that both companies need LARGE reputable buyers to support the price--I think HSOA has a better chance at it if they meet guidance. Also, what institution is going to want to show BBC on their books after the catastrophe of Amarenth?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.